Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Universal Medical Imaging Raises $86 Million to Expand China Imaging Centers

publication date: Feb 10, 2020

Shanghai Universal Medical Imaging Diagnostic company closed an $86 million Series B round to support its China third-party imaging centers that it partners with hospitals. So far, the company has established centers in Shanghai, Hangzhou, Guangzhou, Chongqing and Tianjin, and it plans to add another five centers by the end of 2020. The B round was led by a CEC Capital-owned private equity fund, Cathay Capital, along with V Star Capital, an investment management spinoff from GGV Capital. More details....

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China